Francesco Dotta

Toscana Life Science Park
Siena, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 124 publications

Metabolomic profile differs between LADA and type 1 diabetes identifying tryptophan metabolism as a pathway involved in the heterogeneity of autoimmune diabetes.

Metabolomic profile differs between LADA and type 1 diabetes identifying tryptophan metabolism as a pathway involved in the heterogeneity of autoimmune diabetes.

Journal: Diabetologia

Published: February 20, 2026

From disease heterogeneity to precision therapy in type 1 diabetes mellitus.

From disease heterogeneity to precision therapy in type 1 diabetes mellitus.

Journal: Endocrine

Published: February 19, 2026

Twenty-four-month evaluation of the glycemia risk index in adults with type 1 diabetes using advanced hybrid closed-loop systems.

Twenty-four-month evaluation of the glycemia risk index in adults with type 1 diabetes using advanced hybrid closed-loop systems.

Journal: Endocrine

Published: February 19, 2026

Quantifying the individual disease duration-adjusted burden of complications in persons with type 2 diabetes.

Quantifying the individual disease duration-adjusted burden of complications in persons with type 2 diabetes.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD

Published: February 03, 2026

Functional roles of microRNAs in pancreatic islet autoimmunity: what do we know and where do we target?

Functional roles of microRNAs in pancreatic islet autoimmunity: what do we know and where do we target?

Journal: Expert opinion on therapeutic targets

Published: February 01, 2026

Plasma small RNA profiling reveals a three-miRNA signature associated with early beta cell dysfunction across glucose tolerance stages.

Plasma small RNA profiling reveals a three-miRNA signature associated with early beta cell dysfunction across glucose tolerance stages.

Journal: Diabetologia

Published: December 11, 2025

Functional recovery of islet β cells in human type 2 diabetes: Transcriptome signatures unveil therapeutic approaches.

Functional recovery of islet β cells in human type 2 diabetes: Transcriptome signatures unveil therapeutic approaches.

Journal: Science advances

Published: October 10, 2025

Leveraging circulating microRNAs for personalized disease-modifying therapies in type 1 diabetes.

Leveraging circulating microRNAs for personalized disease-modifying therapies in type 1 diabetes.

Journal: Personalized medicine

Published: September 24, 2025

5'tRNA-derived fragments modulate β-cell homeostasis and islet macrophage activation in type 2 diabetes.

5'tRNA-derived fragments modulate β-cell homeostasis and islet macrophage activation in type 2 diabetes.

Journal: Nature communications

Published: August 29, 2025

Evaluation of short and long-term laboratory and instrumental findings in COVID-19 patients hospitalized in Tuscany.

Evaluation of short and long-term laboratory and instrumental findings in COVID-19 patients hospitalized in Tuscany.

Journal: World journal of experimental medicine

Published: March 25, 2025

Neutrophils in Type 1 Diabetes: Untangling the Intricate Web of Pathways and Hypothesis.

Neutrophils in Type 1 Diabetes: Untangling the Intricate Web of Pathways and Hypothesis.

Journal: Biomolecules

Published: March 03, 2025

The impact of environmental pollution on metabolic health and the risk of non-communicable chronic metabolic diseases in humans.

The impact of environmental pollution on metabolic health and the risk of non-communicable chronic metabolic diseases in humans.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD

Published: January 20, 2025

Showing 1-12 of 124

Last Updated: 09/26/2026